People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Software / Tech, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Medicom Technologies, Inc. | — | Software / Tech | Series B | $42.1M | $74.5M | 2024 |
| Gladius Therapeutics, Inc. | — | Pharma | Pre-Seed | $300K | $2.3M | 2023 |
Michael Seiden at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Seiden on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Justin Wright-Eakes | 1 | 10 |
| Michael Rosenberg | 1 | 6 |
| Mike Becker | 1 | 2 |
| JT Vaughn | 1 | 1 |
| Malcolm Benitz | 1 | 1 |
| Chris Woodlief | 1 | 1 |
| Chase Ballard | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.